Ligand Pharma (LGND) Announces Submission of Baxdela NDAs to FDA as ABSSSI Treatment
Go back to Ligand Pharma (LGND) Announces Submission of Baxdela NDAs to FDA as ABSSSI Treatment| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 71.00 +1.11 (1.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $69.89 | 52 Week High | $139.79 | |||
| Open | $69.46 | 52 Week Low | $82.07 | |||
| Day High | $71.00 | P/E | 165.12 | |||
| Day Low | $69.17 | EPS | $0.43 | |||
| Volume | 152,955 | |||||
